Benjamin L. Caleb
Impact in
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
- Cell Biology top 5%
- Proteoglycans and glycosaminoglycans research
Papers in
-
- Cell Adhesion Molecules Research 3
-
- Proteoglycans and glycosaminoglycans research 3
- Co-authors
- John J. Castellot (5 shared papers)Thomas C. Wright (2 shared papers)Morris J. Karnovsky (2 shared papers)David F. Albertini (1 shared paper)Brian A. Herman (1 shared paper)Kent Wong (1 shared paper)Richard L. Hoover (1 shared paper)Didier Letourneur (2 shared papers)
- Journals
- Journal of Cellular Physiology (4 papers)Molecular Cancer Therapeutics (2 papers)Nature Medicine (1 paper)Cancer Discovery (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Benjamin L. Caleb
12 papers receiving 1.5k citations
Benjamin L. Caleb's Hit Papers
Peers
Comparison fields: 5 of 81
- Immunology and Allergy 117
- Cell Biology 298
- Hematology 193
- Molecular Biology 989
- Cancer Research 196
Countries citing papers authored by Benjamin L. Caleb
This map shows the geographic impact of Benjamin L. Caleb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin L. Caleb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin L. Caleb more than expected).
Fields of papers citing papers by Benjamin L. Caleb
This network shows the impact of papers produced by Benjamin L. Caleb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin L. Caleb. The network helps show where Benjamin L. Caleb may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin L. Caleb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers Hit paper breakdown → | 2018 | 413 |
| 2 | 2008 | 356 | |
| 3 | 1985 | 269 | |
| 4 | 1990 | 121 | |
| 5 | 2017 | 114 | |
| 6 | 2018 | 95 | |
| 7 | 1995 | 63 | |
| 8 | 1995 | 27 | |
| 9 | 2016 | 26 | |
| 10 | 2020 | 16 | |
| 11 | 1996 | 14 | |
| 12 | Preclinical identification of AZD7762, a novel, potent and selective inhibitor of Checkpoint kinases | 2007 | 4 |
About Benjamin L. Caleb
Benjamin L. Caleb is a scholar working on Immunology and Allergy, Cell Biology, Cancer Research, Molecular Biology and Oncology, having authored 12 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (3 papers), Proteoglycans and glycosaminoglycans research (3 papers), RNA Research and Splicing (3 papers), Cancer therapeutics and mechanisms (3 papers), RNA modifications and cancer (2 papers), RNA and protein synthesis mechanisms (2 papers), DNA Repair Mechanisms (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Immunology and Allergy (117 citations), Cell Biology (298 citations), Hematology (193 citations), Molecular Biology (989 citations) and Cancer Research (196 citations). Benjamin L. Caleb has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include John J. Castellot, Thomas C. Wright, Morris J. Karnovsky, David F. Albertini, Brian A. Herman, Kent Wong, Richard L. Hoover, Didier Letourneur, Laurie Pukac and James W. Janetka. Their work appears in journals such as Journal of Cellular Physiology, Molecular Cancer Therapeutics, Nature Medicine, Cancer Discovery and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.